tiprankstipranks
Trending News
More News >
Sangamo Biosciences (SGMO)
NASDAQ:SGMO
US Market

Sangamo Biosciences (SGMO) Income Statement

Compare
2,291 Followers

Sangamo Biosciences Income Statement

Last quarter (Q4 2024), Sangamo Biosciences's total revenue was $7.55M, an increase of 269.78% from the same quarter last year. In Q4, Sangamo Biosciences's net income was $-23.40M. See Sangamo Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 57.80M$ 176.23M$ 111.30M$ 110.70M$ 118.19M
Gross Profit
$ 57.80M$ -45.33M$ 99.19M$ 101.26M$ -62.45M
Operating Expenses
$ 161.77M$ 450.24M$ 312.58M$ 294.04M$ 247.74M
Depreciation and Amortization
$ 9.36M$ 22.19M$ 12.11M$ 9.44M$ 5.68M
EBITDA
$ -89.09M$ -87.43M$ -189.17M$ -173.90M$ -123.87M
Operating Income
$ -103.97M$ -274.00M$ -201.28M$ -183.34M$ -129.55M
Other Income/Expenses
$ 5.86M$ 11.10M$ 9.43M$ 5.35M$ 8.78M
Pretax Income
$ -98.11M$ -262.90M$ -191.85M$ -177.99M$ -120.78M
Net Income
$ -97.94M$ -257.83M$ -192.28M$ -178.30M$ -121.12M
Per Share Metrics
Basic EPS
$ -0.49$ -1.48$ -1.25$ -1.23$ -0.90
Diluted EPS
$ -0.49$ -1.48$ -1.25$ -1.23$ -0.90
Weighted Average Shares Outstanding
201.70M 174.44M 154.34M 144.57M 134.45M
Weighted Average Shares Outstanding (Diluted)
201.70M 174.44M 154.34M 144.57M 134.45M
Currency in USD

Sangamo Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis